Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2016 11:45 ET | Source: Quantum Genomics

Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension

Results enable initiation of additional hypertension studies for lead candidateCompany to conduct a U.S. Phase II trial in targeted patient population based on FDA advice PARIS and NEW YORK, Sept. ...
September 22, 2016 12:00 ET | Source: Quantum Genomics

Quantum Genomics Announces Conference Call to Review Top-line Results from Phase IIa Study of QGC001 in Hypertension

PARIS and NEW YORK, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet...
September 12, 2016 12:00 ET | Source: Quantum Genomics

Quantum Genomics to announce Phase IIa clinical trial results for high blood pressure on September 29, 2016

PARIS and NEW YORK, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet...
September 06, 2016 08:00 ET | Source: Quantum Genomics

Quantum Genomics to Present at Rodman & Renshaw 18th Annual Conference in New York on September 13

CEO Lionel Ségard to discuss clinical updates and latest company developments PARIS and NEW YORK, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a...
May 17, 2016 12:00 ET | Source: Quantum Genomics

Quantum Genomics granted two new U.S. patents covering lead product QGC001

PARIS & NEW YORK, May 17, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company developing new therapies for unmet medical needs in the...
March 24, 2016 08:00 ET | Source: Quantum Genomics

Quantum Genomics Raises €8.6 Million in U.S. and Europe

PARIS and NEW YORK, March 24, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company focused on the development of new therapies for unmet...
February 03, 2016 14:20 ET | Source: Quantum Genomics

Quantum Genomics Expands U.S. Presence to Advance Its Development Programs for Cardiovascular Diseases

Establishes U.S. Clinical Advisory BoardAnnounces Plans to Open U.S. Office PARIS, France, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a...